CATO SMS, a provider of specialized clinical research solutions and a drug development company, completed the acquisition of Array Biostatistics, a biostatistical and statistical programming clinical research organization. Financial terms were not disclosed. "We are excited to welcome Array's impressive team to CATO SMS. They are differentiated by their consultative approach, wealth of industry experience and commitment to client satisfaction. The Array acquisition furthers our goal of providing our clients with a comprehensive portfolio of specialized solutions to best support development in complex therapeutic areas including oncology, rare and orphan indications, and cell and gene therapy, among others," Mark A. Goldberg, CATO SMS Managing Director and Executive Chairman.